Indeed, also in flow cytometric analysis CD81+migcDC1s could be identified by their distinct expression of CD81 and XCR1 and were significantly increased upon Flt3L treatment in the E0771, TS/A and LLC tumor models. This evidence concerns the gene FLT3LG and neoplasm.